Home
About Us
About Us
Board of Directors
Scientific Advisory Board
Management Team
Careers
For Researchers
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
For Partners
Our Current Partners
What We Are Looking For
For Patients
Accessing Kazia Drug Candidates in Clinical Trials
Accessing Kazia Drug Candidates for Compassionate Use
Resources for Patients
For Investors
ASX Announcements
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Investor Newsletters
Corporate Governance
Shareholder Services
Media Centre
Overview
Video
Coverage
Contact
Contact Us
Subscribe to email alerts
Heading &
Sub-heading can be edited through HQI
Home
>
For Researchers
>
Publications and Presentations
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
Publications and Presentations
25-May-2023
EVT801 Phase I Clinical Trial poster presented at AACR23
17-May-2023
Cancer Research publishes pre-clinical findings on DIPG/DMG trial
25-Oct-2022
Poster at Int. Congress of the Society for Melanoma Research
3-Jun-2022
Paxalisib phase II study poster presented as ASCO 2022
4-Jun-2021
Kazia Therapeutics to present at LD Micro Invitational XI
21-Nov-2020
Paxalisib poster presented at SNO (virtual meeting)
22-Jun-2020
Paxalisib poster presented at AACR (virtual meeting)
1-Jun-2020
Paxalisib poster presented at ASCO (virtual meeting)
8-Apr-2020
Ellingson et al (2020) - multiparametric MR-PET in GDC-0084 P1
14-Jan-2020
Wen et al (2020) GDC-0084 phase 1 in glioblastoma
20-Sep-2019
GDC-0084 Poster presented at EANO (Lyon, France)
22-Feb-2019
Ippen et al (2019) - GDC-0084 in brain mets (prelinical)
Click here for archives
